Trial Profile
Safety, tolerabiliy and immunogenicity of a new recombinant anti-hepatitis B vaccine healthy volunteers.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Pharmacodynamics
- 05 Nov 2010 New trial record.